A Study of the TAXUS Liberté Stent for the Treatment of de Novo Coronary Artery Lesions in Small Vessels
Public ClinicalTrials.gov record NCT00371748. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
TAXUS ATLAS SMALL VESSEL: A Multi-center, Single-arm Study of the TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions in Small Vessels
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
TAXUS ATLAS Small Vessel is a global, multi-center, single-arm, trial of patients with coronary arteries less than 2.5 mm in diameter who are treated with the TAXUS Liberté stent versus an historical TAXUS Express control derived from a subset of lesion-matched TAXUS V patients treated with a 2.25 mm stent. The objective of the study is to evaluate clinical and angiographic outcomes of TAXUS Liberté-SR 2.25 mm stent in de novo lesions. The hypothesis is that the TAXUS Liberté-SR stent has non-inferior safety and efficacy to the TAXUS Express-SR stent in the treatment of de novo lesions in small coronary vessels.
Study identification
- NCT ID
- NCT00371748
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 261 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2005
- Primary completion
- Nov 30, 2006
- Completion
- Mar 31, 2011
- Last update posted
- Feb 1, 2012
2005 – 2011
United States locations
- U.S. sites
- 19
- U.S. states
- 17
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mercy General Hospital | Sacramento | California | 95819 | — |
| Christiana Hospital | Newark | Delaware | 19718-0002 | — |
| Florida Hospital | Orlando | Florida | 32803 | — |
| St. John's Hospital | Springfield | Illinois | 62701 | — |
| The Heart Center | Indianapolis | Indiana | 46290 | — |
| Maine Medical Center | Portland | Maine | 04102 | — |
| Washington Adventist Hospital | Takoma Park | Maryland | 20912 | — |
| Northern Michigan Hospital | Petoskey | Michigan | 49770 | — |
| St. Mary's Duluth Clinic Regional Heart Center | Duluth | Minnesota | 55805 | — |
| North Mississippi Medical Center | Tupelo | Mississippi | 38801 | — |
| Columbia University Medical Center | New York | New York | 10032 | — |
| Wake Medical Center | Raleigh | North Carolina | 27610 | — |
| Riverside Methodist Hospital | Columbus | Ohio | 43214 | — |
| North Ohio Research Elyria Memorial Hospital | Elyria | Ohio | 44035 | — |
| Oklahoma Foundation for Cardiovascular Research | Oklahoma City | Oklahoma | 73120 | — |
| The Pennsylvania State University Milton S Hershey Medical Center | Hershey | Pennsylvania | 17033-0850 | — |
| Wellmont Holston Valley Medical Center | Kingsport | Tennessee | 37660 | — |
| Methodist DeBakey Heart Center | Houston | Texas | 77030-2767 | — |
| Scott & White Memorial Hospital | Temple | Texas | 76508 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
Recently updated Coronary Artery Disease trials
Other public records listing Coronary Artery Disease. Sorted by last update posted; newest first. Not a recommendation.
- NCT02061436: Prospective Global Registry for the Study of Chronic Total Occlusion Intervention Recruiting
- NCT07761728: The FLARE (Flurpiridaz vs. Rubidium Evaluation) Trial Recruiting
- NCT05611307: Late Subclinical Cardiovascular Disease in Testicular Cancer Survivors Recruiting
- NCT07258290: Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions Recruiting
- NCT07521007: A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis Not yet recruiting
- NCT05360446: Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00371748, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 1, 2012 · Synced Sep 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00371748 live on ClinicalTrials.gov.